GlassScriptPhysician profile
Irene I Wu
NPI 1699964122
$13,724.91
in general payments reported to CMS, 2019-2025
36 companies · $1,650 in 2025
The $1,650 reported for 2025 was more than what 75% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,592 · 2020: $705 · 2021: $2,119 · 2022: $2,591 · 2023: $2,401 · 2024: $2,667 · 2025: $1,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,718.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,990.69 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Nalu Medical, INC. | $2,969.77 | 2020-2025 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $724.29 | 2022-2024 | Mild Device Kit |
| Depuy Synthes Sales INC. | $696.12 | 2019-2021 | |
| Medtronic, INC. | $600.49 | 2022-2024 | Intellis Adaptivestim, Synchromedii |
| Nevro Corp. | $526.73 | 2023-2024 | Senza |
| Abbott Laboratories | $459.73 | 2019-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $361.36 | 2019-2025 | Belbuca |
| Painteq LLC | $288.56 | 2022-2024 | Painteq |
| Vertiflex, INC. | $268.63 | 2019 | |
| Si-Bone, INC. | $244.25 | 2019-2024 | |
| Flowonix Medical Incorporated | $201.34 | 2019 | |
| Mml US, INC. | $171.03 | 2025 | Reactiv8 |
| Stimwave Technologies Incorporated | $160.57 | 2019-2021 | |
| Medtronic USA, INC. | $157.44 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $125.00 | 2023 | Mounjaro |
| Relievant Medsystems, INC. | $114.12 | 2019-2023 | Intracept |
| Tersera Therapeutics LLC | $91.20 | 2022-2024 | Prialt |
| Stryker Corporation | $73.82 | 2025 | Mild Device Kit |
| Spr Therapeutics, INC | $63.36 | 2022-2023 | Sprint Pns System |
| Curonix LLC | $42.80 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $41.41 | 2019-2021 | |
| Saluda Medical Americas, INC. | $34.32 | 2025 | Evoke |
| Vertex Pharmaceuticals Incorporated | $33.30 | 2025 | |
| Biotronik Nro, INC. | $32.70 | 2025 | Prospera |
| Grt US Holding, INC. | $30.52 | 2021 | |
| Abbvie INC. | $29.36 | 2023 | Botox |
| Iovance Biotherapeutics, INC. | $29.29 | 2025 | Amtagvi |
| Astrazeneca Pharmaceuticals LP | $28.91 | 2025 | |
| Astellas Pharma US INC | $26.85 | 2025 | Padcev |
| Avanos Medical | $20.43 | 2022 | |
| Piramal Critical Care | $20.25 | 2019 | |
| Averitas Pharma INC. | $19.19 | 2023 | Qutenza |
| Ipsen Biopharmaceuticals, INC | $17.63 | 2019 | |
| West Therapeutics Development, LLC | $15.74 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.